Terrence Michael Gibbs Net Worth & Insider Trades
Terrence Michael Gibbs - General Counsel, T2 Biosystems, Inc
What is Terrence Michael Gibbs's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's General Counsel, Terrence Michael Gibbs, is estimated to be about $144.37K . Terrence Michael Gibbs owns about 166,651 units of T2 Biosystems, Inc common stock. In the last 6 years at T2 Biosystems, Inc, Terrence Michael Gibbs has sold an estimated value of $201.3K worth.
What is Terrence Michael Gibbs's Past Insider Trading?
Terrence Michael Gibbs's largest purchase order was 10,000 units , worth over $4.9K on April 11, 2022. Terrence Michael Gibbs's largest sale order was 6,907 units , worth over $49.56K on June 8, 2018. In total, Terrence Michael Gibbs has made about 23 transactions over 6 years of their time at T2 Biosystems, Inc. Terrence Michael Gibbs usually trades in February, with the busiest year in 2018.
Terrence Michael Gibbs
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Terrence Michael Gibbs's' Mailing Address?
- Mailing address is 12 Stoney Brook Rd. Hopkinton MA 01748 MA
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on November 22, 2022 by Brett Giffin who sold 1,292 units worth $2.32K . In the last 8 years, insiders at T2 Biosystems, Inc have sold an estimated value of $9.08M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, David Elsbree, Director, and Terrence Michael Gibbs, General Counsel .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||